Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SMTC +4.6%, CNS +2.5%, AA +2.3%, WAFD +1.5%
Other news:
- SITC +18.3% (Declared a $3.00-per-share special cash distribution after selling joint-venture interests for $32.4 million.)
- TSLA +3.5% (Introduces the new Tesla Roadster.)
- VRNS +2.6% (Agreed to be acquired by Proofpoint for $49.75 per share in cash, valuing Varonis at approximately $6.3 billion.)
- INSW +2.6% (Agreed to acquire Bruton for approximately $370 million, adding four VLCCs, as early Q4 spot earnings accelerated.)
- MGNX +2.1% (Dosed the first patient in a Phase 1 study of MGC030 for advanced solid tumors.)
- MMED +1.9% (Named its board after completing its separation from Medtronic and becoming an independent diabetes-focused company.)
- CBIO +1.8% (Completed ASCEND dose escalation for CR-001, with initial monotherapy data expected in Q1 2027.)
- HPP +1.6% (Sold Skyport Plaza for $75.5 million, with proceeds earmarked to reduce its unsecured revolving credit facility.)